Helsinn Healthcare
Helsinn Healthcare, a Swiss-based pharmaceutical company, has established itself as a leader in the oncology and supportive care sectors since its founding in 1977. Headquartered in Lugano, Switzerland, Helsinn operates globally, with significant presence in Europe, North America, and Asia. The company is renowned for its innovative approach to developing high-quality products that enhance the quality of life for cancer patients, including its flagship anti-emetic treatments. With a strong commitment to research and development, Helsinn has achieved notable milestones, including strategic partnerships and a robust pipeline of therapies. Its dedication to patient-centric solutions and a focus on unmet medical needs have positioned Helsinn as a trusted name in the healthcare industry, recognised for its contributions to cancer care and supportive therapies.
DitchCarbon Score
How does Helsinn Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Helsinn Healthcare's score of 21 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Helsinn Healthcare's reported carbon emissions
In 2021, Helsinn Healthcare, headquartered in Switzerland (CH), reported total carbon emissions of approximately 3,370,000 kg CO2e. This figure includes Scope 1 emissions of about 1,175,000 kg CO2e, Scope 2 emissions of around 340,000 kg CO2e, and significant Scope 3 emissions totalling approximately 1,855,000 kg CO2e. Notably, business travel accounted for about 765,000 kg CO2e, while employee commuting contributed approximately 645,000 kg CO2e. Helsinn Healthcare has not publicly disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The company has not cascaded emissions data from a parent organization, indicating that its reported figures are independently sourced. The emissions data reflects a comprehensive approach to understanding and managing carbon footprints across various scopes, although no specific reduction commitments have been outlined. As the company continues to assess its environmental impact, future disclosures may provide insights into potential climate strategies and targets.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2012 | 2013 | 2014 | 2015 | 2016 | 2021 | |
|---|---|---|---|---|---|---|
| Scope 1 | 2,955,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | - | - | - | 0,000,000 | 0,000,000 | 000,000 |
| Scope 3 | - | - | - | 0,000,000 | 0,000,000 | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Helsinn Healthcare is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
